ALY-301

N/A

Report date: 2025/10/20 14:18:13

Base Information

Drug NameALY-301

Drug Alias NameALY-301GTX-B001

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionAnti-Stem cell growth factor receptorAnti-Ectonucleotide pyrophosphatase/phosphodiesterase family member 3

TargetsStem cell growth factor receptorEctonucleotide pyrophosphatase/phosphodiesterase family member 3

Therapy Area/IndicationsSymptomatic DermographismChronic UrticariaUrticaria

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesGermany

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesAlys Pharmaceuticals Inc

China Registration ClassN/A

Develop Information

Active CompaniesAlys Pharmaceuticals Inc

Inactive CompaniesN/A

Active IndicationsSymptomatic DermographismChronic UrticariaUrticaria

Inactive IndicationsN/A

Other Information

ATC CodeN/A